cached image

Amy C. Arai - Publications

Pharmacology Southern Illinois University at Carbondale, Carbondale, IL 
Pharmacology, Neuroscience Biology, Biochemistry

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Harms JE, Benveniste M, Kessler M, Stone LM, Arai AC, Partin KM. A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators. The Journal of Biological Chemistry. 289: 10702-14. PMID 24550387 DOI: 10.1074/jbc.M113.526921  1
2011 Xia YF, Arai AC. Prolactin-releasing peptide enhances synaptic transmission in rat thalamus. Neuroscience. 172: 1-11. PMID 21056089 DOI: 10.1016/j.neuroscience.2010.10.079  1
2009 Montgomery KE, Kessler M, Arai AC. Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations. The Journal of Pharmacology and Experimental Therapeutics. 331: 965-74. PMID 19717789 DOI: 10.1124/jpet.109.158014  1
2009 Arai AC. The role of kisspeptin and GPR54 in the hippocampus. Peptides. 30: 16-25. PMID 18765263 DOI: 10.1016/j.peptides.2008.07.023  1
2008 Arai AC, Orwig N. Factors that regulate KiSS1 gene expression in the hippocampus. Brain Research. 1243: 10-8. PMID 18834866 DOI: 10.1016/j.brainres.2008.09.031  1
2008 Kessler M, Kiliman B, Humes C, Arai AC. Spontaneous activity in Purkinje cells: multi-electrode recording from organotypic cerebellar slice cultures. Brain Research. 1218: 54-69. PMID 18533133 DOI: 10.1016/j.brainres.2008.04.063  1
2008 Kessler M, Suzuki E, Montgomery K, Arai AC. Physiological significance of high- and low-affinity agonist binding to neuronal and recombinant AMPA receptors. Neurochemistry International. 52: 1383-93. PMID 18403051 DOI: 10.1016/j.neuint.2008.02.009  1
2008 Suzuki E, Kessler M, Arai AC. The fast kinetics of AMPA GluR3 receptors is selectively modulated by the TARPs gamma 4 and gamma 8. Molecular and Cellular Neurosciences. 38: 117-23. PMID 18395463 DOI: 10.1016/j.mcn.2008.01.018  1
2007 Wu Y, Arai AC, Rumbaugh G, Srivastava AK, Turner G, Hayashi T, Suzuki E, Jiang Y, Zhang L, Rodriguez J, Boyle J, Tarpey P, Raymond FL, Nevelsteen J, Froyen G, et al. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proceedings of the National Academy of Sciences of the United States of America. 104: 18163-8. PMID 17989220 DOI: 10.1073/pnas.0708699104  1
2007 Montgomery K, Suzuki E, Kessler M, Arai AC. Factors affecting guanine nucleotide binding to rat AMPA receptors. Brain Research. 1177: 1-8. PMID 17884024 DOI: 10.1016/j.brainres.2007.08.021  1
2007 Arai AC, Kessler M. Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior Current Drug Targets. 8: 583-602. PMID 17504103 DOI: 10.2174/138945007780618490  1
2006 Kessler M, Arai AC. Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators. Brain Research. 1076: 25-41. PMID 16256076 DOI: 10.1016/j.brainres.2005.09.024  1
2005 Arai AC, Xia YF, Suzuki E, Kessler M, Civelli O, Nothacker HP. Cancer metastasis-suppressing peptide metastin upregulates excitatory synaptic transmission in hippocampal dentate granule cells. Journal of Neurophysiology. 94: 3648-52. PMID 16222076 DOI: 10.1152/jn.00590.2005  1
2005 Xia YF, Arai AC. AMPA receptor modulators have different impact on hippocampal pyramidal cells and interneurons. Neuroscience. 135: 555-67. PMID 16125852 DOI: 10.1016/j.neuroscience.2005.06.031  1
2005 Suzuki E, Kessler M, Arai AC. C-terminal truncation affects kinetic properties of GluR1 receptors. Molecular and Cellular Neurosciences. 29: 1-10. PMID 15866042 DOI: 10.1016/j.mcn.2005.01.004  1
2005 Xia YF, Kessler M, Arai AC. Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 313: 277-85. PMID 15626725 DOI: 10.1124/jpet.104.078196  1
2004 Suzuki E, Kessler M, Montgomery K, Arai AC. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Molecular Pharmacology. 66: 1738-47. PMID 15448189 DOI: 10.1124/mol.104.003038  1
2004 Kramár EA, Lin B, Lin CY, Arai AC, Gall CM, Lynch G. A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5151-61. PMID 15175384 DOI: 10.1523/JNEUROSCI.0800-04.2004  1
2004 Arai AC, Xia YF, Suzuki E. Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus. Neuroscience. 123: 1011-24. PMID 14751292 DOI: 10.1016/j.neuroscience.2003.10.033  1
2003 Lin B, Arai AC, Lynch G, Gall CM. Integrins regulate NMDA receptor-mediated synaptic currents. Journal of Neurophysiology. 89: 2874-8. PMID 12740418 DOI: 10.1152/jn.00783.2002  1
2002 Arai AC, Xia YF, Rogers G, Lynch G, Kessler M. Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. The Journal of Pharmacology and Experimental Therapeutics. 303: 1075-85. PMID 12438530 DOI: 10.1124/jpet.102.040360  1
2002 Lin B, Colgin LL, Brücher FA, Arai AC, Lynch G. Interactions between recording technique and AMPA receptor modulators. Brain Research. 955: 164-73. PMID 12419533 DOI: 10.1016/S0006-8993(02)03429-7  1
2002 Lin SH, Arai AC, España RA, Berridge CW, Leslie FM, Huguenard JR, Vergnes M, Civelli O. Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures. Neuroscience. 114: 229-38. PMID 12207968 DOI: 10.1016/S0306-4522(02)00248-8  1
2002 Arai AC, Xia YF, Kessler M, Phillips D, Chamberlin R, Granger R, Lynch G. Effects of 5'-alkyl-benzothiadiazides on (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor biophysics and synaptic responses. Molecular Pharmacology. 62: 566-77. PMID 12181433 DOI: 10.1124/mol.62.3.566  1
2002 Phillips D, Sonnenberg J, Arai AC, Vaswani R, Krutzik PO, Kleisli T, Kessler M, Granger R, Lynch G, Richard Chamberlin A. 5'-alkyl-benzothiadiazides: a new subgroup of AMPA receptor modulators with improved affinity. Bioorganic & Medicinal Chemistry. 10: 1229-48. PMID 11886787 DOI: 10.1016/S0968-0896(01)00405-9  1
2001 Lin SH, Arai AC, Wang Z, Nothacker HP, Civelli O. The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. Molecular Pharmacology. 60: 916-23. PMID 11641419  1
2001 Arai AC. GYKI 52466 has positive modulatory effects on AMPA receptors Brain Research. 892: 396-400. PMID 11172790 DOI: 10.1016/S0006-8993(00)03323-0  1
2000 Arai AC, Kessler M, Rogers G, Lynch G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: Interactions with cyclothiazide and GYKI 52466 Molecular Pharmacology. 58: 802-813. PMID 10999951  1
2000 Kessler M, Rogers G, Arai A. The norbornenyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits. Neuroscience Letters. 287: 161-5. PMID 10854736  1
2000 Lauterborn JC, Lynch G, Vanderklish P, Arai A, Gall CM. Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8-21. PMID 10627576  1
1999 Johnson SA, Luu NT, Herbst TA, Knapp R, Lutz D, Arai A, Rogers GA, Lynch G. Synergistic interactions between ampakines and antipsychotic drugs. The Journal of Pharmacology and Experimental Therapeutics. 289: 392-7. PMID 10087029  1
1998 Arai A, Lynch G. AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices. Brain Research. 799: 235-42. PMID 9675296  1
1998 Arai A, Lynch G. The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization. Brain Research. 799: 230-4. PMID 9675293  1
1997 Davis CM, Moskovitz B, Nguyen MA, Tran BB, Arai A, Lynch G, Granger R. A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors. Psychopharmacology. 133: 161-7. PMID 9342782  1
1997 Hennegriff M, Arai A, Kessler M, Vanderklish P, Mutneja MS, Rogers G, Neve RL, Lynch G. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators. Journal of Neurochemistry. 68: 2424-34. PMID 9166736  1
1996 Arai A, Kessler M, Ambros-Ingerson J, Quan A, Yigiter E, Rogers G, Lynch G. Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics Neuroscience. 75: 573-585. PMID 8931020 DOI: 10.1016/0306-4522(96)00263-1  1
1996 Arai A, Guidotti A, Costa E, Lynch G. Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices. Neuroreport. 7: 2211-5. PMID 8930991  1
1996 Arai A, Kessler M, Rogers G, Lynch G. Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 278: 627-38. PMID 8768713  1
1996 Arai A, Lynch G. Response to repetitive stimulation of AMPA receptors in patches excised from fields CA1 and CA3 of the hippocampus. Brain Research. 716: 202-6. PMID 8738240 DOI: 10.1016/0006-8993(96)00030-3  1
1996 Kessler M, Arai A, Quan A, Lynch G. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: Lack of competition between cyclothiazide and GYKI 52466 Molecular Pharmacology. 49: 123-131. PMID 8569697  1
1995 Arai A, Silberg J, Lynch G. Differences in the refractory properties of two distinct inhibitory circuitries in field CA1 of the hippocampus. Brain Research. 704: 298-306. PMID 8788926  1
1995 Arai A, Silberg J, Kessler M, Lynch G. Effect of thiocyanate on AMPA receptor mediated responses in excised patches and hippocampal slices. Neuroscience. 66: 815-27. PMID 7544449  1
1995 Vanderklish P, Saido TC, Gall C, Arai A, Lynch G. Proteolysis of spectrin by calpain accompanies theta-burst stimulation in cultured hippocampal slices. Brain Research. Molecular Brain Research. 32: 25-35. PMID 7494460  1
1994 del Cerro S, Arai A, Kessler M, Bahr BA, Vanderklish P, Rivera S, Lynch G. Stimulation of NMDA receptors activates calpain in cultured hippocampal slices. Neuroscience Letters. 167: 149-52. PMID 8177514 DOI: 10.1016/0304-3940(94)91049-9  1
1994 Arai A, Black J, Lynch G. Origins of the variations in long-term potentiation between synapses in the basal versus apical dendrites of hippocampal neurons. Hippocampus. 4: 1-9. PMID 8061748 DOI: 10.1002/hipo.450040103  1
1994 Arai A, Kessler M, Xiao P, Ambros-Ingerson J, Rogers G, Lynch G. A centrally active drug that modulates AMPA receptor gated currents. Brain Research. 638: 343-6. PMID 7911064  1
1992 Arai A, Lynch G. Antagonists of the Platelet-activating Factor Receptor Block Long-term Potentiation in Hippocampal Slices. The European Journal of Neuroscience. 4: 411-419. PMID 12106349  1
1992 Arai A, Lynch G. Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation. Brain Research. 598: 173-84. PMID 1486479  1
1992 Vanderklish P, Neve R, Bahr BA, Arai A, Hennegriff M, Larson J, Lynch G. Translational suppression of a glutamate receptor subunit impairs long-term potentiation. Synapse (New York, N.Y.). 12: 333-7. PMID 1465743 DOI: 10.1002/syn.890120410  1
1992 Muller D, Arai A, Lynch G. Factors governing the potentiation of NMDA receptor-mediated responses in hippocampus. Hippocampus. 2: 29-38. PMID 1364046 DOI: 10.1002/hipo.450020105  1
1991 Arai A, Vanderklish P, Kessler M, Lee K, Lynch G. A brief period of hypoxia causes proteolysis of cytoskeletal proteins in hippocampal slices. Brain Research. 555: 276-80. PMID 1933340  1
1991 Lee KS, Frank S, Vanderklish P, Arai A, Lynch G. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proceedings of the National Academy of Sciences of the United States of America. 88: 7233-7. PMID 1871130  1
1991 Kessler M, Arai A, Vanderklish P, Lynch G. Failure to detect changes in AMPA receptor binding after long-term potentiation. Brain Research. 560: 337-41. PMID 1684732  1
1990 Arai A, Larson J, Lynch G. Anoxia reveals a vulnerable period in the development of long-term potentiation. Brain Research. 511: 353-7. PMID 2334854  1
1990 Arai A, Kessler M, Lee K, Lynch G. Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices. Brain Research. 532: 63-8. PMID 2178038  1
1990 Lynch G, Kessler M, Arai A, Larson J. The nature and causes of hippocampal long-term potentiation. Progress in Brain Research. 83: 233-50. PMID 2168058  1
1990 Arai A, Baudry M, Staubli U, Lynch G, Gall C. Induction of ornithine decarboxylase by subseizure stimulation in the hippocampus in vivo. Brain Research. Molecular Brain Research. 7: 167-9. PMID 2160044  1
1990 Arai A, Kessler M, Lynch G. The effects of adenosine on the development of long-term potentiation. Neuroscience Letters. 119: 41-4. PMID 2097583  1
1990 del Cerro S, Arai A, Lynch G. Inhibition of long-term potentiation by an antagonist of platelet-activating factor receptors. Behavioral and Neural Biology. 54: 213-7. PMID 1964041  1
Show low-probability matches.